Orthofix Expects 2024 Net Sales To Range $785M-$795M (Est. $741.55M), Expects To Exit Q4 2024 Free Cash Flow Positive
Portfolio Pulse from Benzinga Newsdesk
Orthofix projects its 2024 net sales to be between $785M-$795M and anticipates becoming free cash flow positive by Q4 2024. The company also forecasts a significant increase in its non-GAAP adjusted EBITDA, estimating it to be between $62M-$67M, which represents a $15.7M-$20.7M rise compared to the full year 2023.
March 05, 2024 | 9:32 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Orthofix expects its 2024 net sales to be in the range of $785M-$795M and to exit Q4 2024 free cash flow positive. The company also anticipates a significant increase in its non-GAAP adjusted EBITDA, estimating it to be between $62M-$67M, which is a $15.7M-$20.7M increase over the full year 2023.
Orthofix's projection of increased net sales and positive free cash flow by Q4 2024, along with a significant rise in non-GAAP adjusted EBITDA, indicates a strong financial outlook. This positive forecast is likely to instill investor confidence, potentially leading to a short-term increase in the stock price.
CONFIDENCE 90
IMPORTANCE 90
RELEVANCE 100